Farnum v. Iris Biotechnologies Inc.

CourtCalifornia Court of Appeal
DecidedDecember 19, 2022
DocketH047850
StatusPublished

This text of Farnum v. Iris Biotechnologies Inc. (Farnum v. Iris Biotechnologies Inc.) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Farnum v. Iris Biotechnologies Inc., (Cal. Ct. App. 2022).

Opinion

Filed 12/19/2022 CERTIFIED FOR PUBLICATION

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SIXTH APPELLATE DISTRICT

DANIEL S. FARNUM, H047850 (Santa Clara County Plaintiff and Appellant, Super. Ct. No. 2015CV280783)

v.

IRIS BIOTECHNOLOGIES INC.,

Defendant and Respondent.

Appellant Daniel S. Farnum appeals from the trial court’s order denying his request, pursuant to Corporations Code section 1604,1 for an award of his reasonable expenses related to his demand for the inspection of respondent Iris Biotechnologies Inc.’s (Iris) records. Farnum argues that the trial court “made erroneous factual conclusions” and thus its order must be reversed. As explained below, we disagree and will affirm the order. I. FACTUAL AND PROCEDURAL BACKGROUND A. Procedure We briefly recount the salient facts, as laid out in our prior opinion (Farnum v. Iris Biotechnologies, Inc. (Nov. 29, 2018, H042858) [nonpub. opn.] (Farnum)) and the other documents in the record on appeal. Iris is a life sciences company incorporated in California in February 1999. The company went public in December 2007, but in August 2019, the Securities and Exchange Commission (SEC) revoked the registration of Iris’s securities. Since its

1 Unspecified statutory references are to the Corporations Code. incorporation, Simon Chin has been chairman of Iris’s three-member board of directors, its president, secretary, chief executive officer, chief financial officer, and majority shareholder. Chin’s sister, Grace Osborne, has also been a member of the board of directors. Farnum was a member of the board of directors from March 2003 until November 2014 and, at the time our prior opinion was issued, owned approximately 8 percent of Iris’s stock.2 In September 2014, Farnum requested inspection of corporate minutes, documents relating to the acquisition of Iris’s subsidiary, and monthly cash flow statements following the acquisition. In October 2014, Farnum, in his capacity as a member of the board of directors and a shareholder, petitioned for a writ of mandate directing Iris to permit him to inspect and copy all corporate records.3 Prior to the hearing on Farnum’s petition, Farnum was voted off Iris’s board of directors. The superior court denied Farnum’s petition under section 1602 because Farnum no longer had standing to inspect corporate records due to his ejection from the board of directors. The superior court also denied Farnum’s petition, without prejudice, pursuant to former section 1601, on the ground that Farnum’s request was “overbroad and lack[ed] a statement of purpose reasonably related to his interests as a shareholder.”

2 We do not know the current status of Farnum’s ownership interest in Iris given the SEC’s revocation of Iris’s securities registration. We presume that if it had any bearing on the outcome of the proceedings below or this appeal, Farnum would have raised it in his opening brief. 3 Section 1602 affords a director an “absolute right at any reasonable time to inspect and copy all books, records and documents of every kind.” Under former section 1601, subdivision (a)(1) “[t]he accounting books and records and minutes of proceedings of the shareholders and the board and committees of the board of any domestic corporation . . . shall be open to inspection . . . upon the written demand on the corporation of any shareholder . . . at any reasonable time during usual business hours, for a purpose reasonably related to the holder’s interests as a shareholder.”

2 A few weeks later, Farnum served a set of 31 inspection requests on Iris, seeking to inspect a wide range of documents from both Iris and its subsidiary, Iris Wellness Labs, Inc.4 Iris’s counsel responded to the request indicating that certain documents, such as shareholder and board minutes, were not maintained and could not be produced,5 but that audited financial statements from 2012 to 2014 had already been provided to Farnum. Through counsel, Iris indicated the remaining requests were not permitted under California law and therefore no responsive documents would be produced. Farnum thereafter filed another petition for writ of mandate seeking to compel inspection and copying of corporate records in his capacity as a shareholder. After a hearing in August 2015, the superior court denied both the petition and Farnum’s associated request for an award of attorney fees. Farnum appealed. In Farnum, supra, (Nov. 29, 2018, H042858) [nonpub. opn.], this court reversed the order denying the writ petition, holding that Farnum had a right to inspect “certain accounting and financial records.” (Id. at p. 20.) The court specifically noted, however, that the majority of Farnum’s 31 inspection requests were for “categories of corporate records that were neither financial nor accounting records,” specifically Farnum’s requests Nos. 5, 10 through 16, 18 through 20, 22, 24 through 27, and 29 through 31. (Id. at pp. 14-15.) The court held that Farnum had “no right as a shareholder to inspect and copy these records.” (Id. at p. 15.) As to most of the remaining requests (Nos. 3, 6-9, 21, 23, & 28), the court determined that, as a shareholder, Farnum was entitled to examine the records at issue,

4 The full list of requests is set forth in our prior opinion and we will not repeat it here. (See Farnum, supra, (Nov. 29, 2018, H042858) [nonpub. opn.] at p. 3.) 5 In a subsequent e-mail, Iris’s counsel clarified that Iris did not hold annual shareholders’ meetings from 2007 up until November 2014 and attached a copy of the minutes from the November 14, 2014 shareholders’ meeting. Counsel also noted that the minutes from the September 29, 2014 board of directors’ meeting had already been provided to Farnum.

3 with specified limitations in scope.6 However, although request No. 17 sought financial and accounting records, the court concluded that the trial court properly denied this request because Iris had indicated it had no responsive documents.7 Finally, in response to Farnum’s request for expenses, including attorney fees, under section 1604, our prior opinion stated: “Here, on remand, the superior court may award an amount to reimburse Farnum for his expenses incurred before the superior court and on appeal.” (Farnum, supra, (Nov. 29, 2018, H042858) [nonpub. opn.] at p. 20.) B. Proceedings on remand Farnum subsequently filed a motion pursuant to section 1604 seeking reimbursement of his expenses, including attorney fees, in enforcing his rights as a shareholder to inspect Iris’s records. Farnum argued that he was entitled to recovery of approximately $91,000 in attorney fees and costs because Iris’s withholding of responsive records was “ ‘without justification.’ ” Chin, apparently believing he could appear on behalf of Iris in propria persona, filed a “return” to Farnum’s motion. Farnum objected to the “return,” noting that Chin could not appear on Iris’s behalf. He asked that the trial court strike the response and award his fees and expenses in full.

6 For example, in connection with request No. 6, in which Farnum sought records of “all benefits paid to . . . Chin since December 2007,” the court concluded Farnum was entitled to inspect the records covering the period between December 2007 and December 2011, as well as 2014, but not the records for 2012 to 2013, as he had not shown those records were “erroneous or incomplete.” (Farnum, supra, at pp. 17-18.) With respect to request Nos. 21, 23, and 28, the court similarly found Farnum had no right to inspect Iris’s records from 2012 and 2013 relating to those requests because Farnum had not shown the audited statements from those years were erroneous or incomplete. (Id. at pp. 18-20.) 7 Our prior opinion does not mention request Nos. 1, 2, or 4, nor does Farnham raise those requests in his current briefing. Presumably they were not significant to the prior appeal.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Vernon S. v. Jerome C.
906 P.2d 1275 (California Supreme Court, 1995)
Mary M. v. City of Los Angeles
814 P.2d 1341 (California Supreme Court, 1991)
Common Cause v. Stirling
119 Cal. App. 3d 658 (California Court of Appeal, 1981)
Valtz v. Penta Investment Corp.
139 Cal. App. 3d 803 (California Court of Appeal, 1983)
Moran v. Oso Valley Greenbelt Ass'n
12 Cal. Rptr. 3d 435 (California Court of Appeal, 2004)
Moran v. OSO VALLEY GREENBELT ASS'N
111 Cal. Rptr. 2d 636 (California Court of Appeal, 2001)
Chantiles v. Lake Forest II Master Homeowners Ass'n
37 Cal. App. 4th 914 (California Court of Appeal, 1995)
Connerly v. State Personnel Board
129 P.3d 1 (California Supreme Court, 2006)
Jameson v. Desta
420 P.3d 746 (California Supreme Court, 2018)
Doe v. United States Swimming, Inc.
200 Cal. App. 4th 1424 (California Court of Appeal, 2011)
Hernandez v. First Student, Inc.
249 Cal. Rptr. 3d 681 (California Court of Appeals, 5th District, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
Farnum v. Iris Biotechnologies Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/farnum-v-iris-biotechnologies-inc-calctapp-2022.